NCT06649916Recruiting
Word Learning From Parentese in Autistic Children
Autism Word Learning and Infant Directed-Speech
Source: ClinicalTrials.gov · Last updated 28 Oct 2026
Brief summary (registry, in English)
The overall objective of this research is to determine whether parentese delivered in the video format (Aim 1) and in live interaction (Aim 2) facilitates novel word learning in autistic children and to investigate if there are factors that influence the effect of parentese on word learning (Aim 3).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 17 Oct 2024
- Start date
- 4 Oct 2024
- Primary completion date
- 1 Mar 2028
- Lead sponsor
- The University of Texas at Dallas
- Diseases
- Autism
- NCT number
- NCT06649916
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 4 Oct 2024 to the primary completion date, 1 Mar 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- has uncorrected visual impairment or hearing impairment
- has developmental disorders or medical conditions other than ASD that affect language or cognition (excepting psychiatric conditions often comorbid with ASD such as ADHD)
Other
- hears another language more than 10% of time based on parent report
Who the study is looking for
- children with or without a diagnosis of ASD between 18 and 59 months
Age in the registry: 18 months to 59 months · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Texas at Dallas Coordinator of this site? Confirm its status | Richardson | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.